Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

282.82 +9.78 (+3.58%)
Delayed Quote Updated: 11:37 AM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
39 40 Next >
News headline image
Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash. 
Via Benzinga
Illumina, Inc. (NASDAQ: ILMN) is a Leading Gainer in Monday Morning Trading
Via Investor Brand Network
News headline image
Illumina Surges As Activist Carl Icahn Reportedly Steps In Over Grail ↗
Icahn is reportedly planning a proxy fight with Illumina, frustrated by the Grail efforts. 
Via Investor's Business Daily
News headline image
Why Illumina Shares Are Soaring Today? ↗
 
Via Benzinga
News headline image
A Look Into Illumina's Debt ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Illumina? ↗
 
Via Benzinga
News headline image
DNA-Reading Giant Illumina Topples On Wide Profit Miss ↗
Sales narrowly topped expectations, however. 
Via Investor's Business Daily
News headline image
Illumina, Seagen And Other Big Stocks Moving Higher On Monday ↗
U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Why Is ROKU Stock Down Today? ↗
Roku (ROKU) stock is taking a beating on Monday after it was revealed a large portion of the company's funds were held at Silicon Valley Bank. 
Via InvestorPlace
News headline image
ILMN Stock Alert: What to Know as Carl Icahn Prepares for Proxy Fight With Illumina ↗
Illumina (ILMN) stock is a hot topic among traders on Monday as reports claim Carl Icahn is gearing up for a proxy fight. 
Via InvestorPlace
News headline image
Nasdaq Futures Climb Solidly After Past Week's Rout: Analyst Flags Key S&P 500 Support To Stay Above October Lows ↗
After the market mayhem seen last week, some semblance of normalcy could return to Wall Street, thanks to the government’s move to assuage concerns in response to the banking crisis. 
Via Benzinga
News headline image
If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today ↗
 
Via Benzinga
News headline image
Earnings Preview For Illumina ↗
 
Via Benzinga
7 Analysts Have This to Say About Illumina ↗
 
Via Benzinga
News headline image
Church & Dwight, A. O. Smith, Illumina And This US Bank Are CNBC's 'Final Trades' ↗
On CNBC’s "Halftime Report Final Trades," Joseph Terranova of Virtus Investment Partners said Church & Dwight Co., Inc. (NYSE: CHD) has consolidated the recent gains and is likely 
Via Benzinga
News headline image
DNA Sequencing and Service Market May See a Big Move : Abbott Laboratories, Eurofins Scientific, Illumina
Stay up-to-date with DNA Sequencing and Service Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
News headline image
Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industry 
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
The Next Generation Of Cancer Vaccines Are Coming; What That Means For Moderna And Other Biotech Stocks ↗
Startling cancer vaccine results from Moderna may point to the next big thing in biotech. 
Via Investor's Business Daily
News headline image
Home Healthcare Equipment Market Trends, Volume, Growth Strategies Forecast Report 2023
Some of the major players profiled in the Home Healthcare Equipment Market report are Abbott Laboratories (US), F. Hoffman-La Roche (Switzerland), QIAGEN (Germany), Thermo Fisher Scientific (US),... 
Via SBWire
Topics Economy
News headline image
Cri-Du-Chat Syndrome Market Demand Trends Size Overview Analysis 2022-2029
Global Cri-du-chat Syndrome Market to Witness Huge Growth by Key Players: Centogene AG, Eurofins Scientific, Laboratory Corporation of America Holdings, Quest Diagnostics, PerkinElmer Inc., Natera,... 
Via SBWire
News headline image
7 Stocks to Buy and Hold for the Next 20 Years ↗
When choosing stocks to buy and hold for the next 20 years, pick companies with strong comparative advantages in durable sectors. 
Via InvestorPlace
News headline image
Cramer Likens This Stock To 'A Fine Merlot': It's Down 1% In 2023, So 'I Would Buy All You Can Right Here' ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Parker-Hannifin Corp (NYSE: PH) is "just the kind of industrial I’ve been recommending." 
Via Benzinga
News headline image
New Survey Data Shows Innovation Teams at Large Companies Are Focusing More on Near-Term Initiatives, but Internal Politics and Culture Remain Top Challenges
InnoLead has released a 2023 update to its popular Benchmarking Innovation Impact research with KPMG LLP. 
Via Newswire.com
News headline image
US Stocks Pause Ahead Of Powell's Speech: Analyst Warns Of Retest Of October Lows As Market, Economic Data Conspire Against Monetary Policy ↗
Stocks look set for another nervous session on Tuesday as traders look ahead to comments from Fed Chair Jerome Powell and another batch of earnings reports. Cues From Monday’s Trading: 
Via Benzinga
News headline image
Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover ↗
Danaher is reportedly looking to add to its wheelhouse to compete with Thermo. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For January 25, 2023 ↗
 
Via Benzinga
News headline image
Healthcare Sector Is Lagging As We Enter 2022 Earnings Season ↗
The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength. 
Via Talk Markets
News headline image
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review ↗
Sharp Tesla price cuts and some notable earnings were in focus. 
Via Investor's Business Daily
News headline image
Illumina Shares Tank After Annual Guidance Fall Short Of Expectations ↗
 
Via Benzinga
News headline image
Universal Sequencing Technology Corporation (UST) partners with TATAA Biocenter to offer Long Read Sequencing Services with TELL-Seq Linked-Read Tech
CARLSBAD, Calif. - Jan. 10, 2023 - PRLog -- Universal Sequencing Technology Corporation (UST) announces today, January 10th, 2022, that it has partnered with TATAA Biocenter, one of our key... 
Via PRLog
Topics Intellectual Property
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.